Xin-Jun Huang
Overview
Explore the profile of Xin-Jun Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xia W, Lv X, Liang H, Liu G, Sun R, Zeng Q, et al.
Clin Cancer Res
. 2021 Jun;
27(15):4186-4194.
PMID: 34083231
Purpose: Previous studies suggest that a cumulative cisplatin dose of 200 mg/m might be adequate in the intensity-modulated radiation therapy (IMRT) era for locoregionally advanced nasopharyngeal carcinoma (LANPC). However, two...
2.
Yang Q, Zhao T, Qiang M, Hu L, Lv X, Ye Y, et al.
J Cancer
. 2018 Sep;
9(17):3023-3031.
PMID: 30210624
To date, no guidelines exist for elderly nasopharyngeal carcinoma (NPC) patients (60 years of age or older) due to a lack of prospective clinical trials. This study evaluated the efficacy...
3.
Liang H, Lv X, Wang L, Wu Y, Sun R, Ye Y, et al.
Ther Adv Med Oncol
. 2018 Jul;
10:1758835918782331.
PMID: 30046357
Background: In the intensity-modulated radiotherapy (IMRT) era, the survival benefit of concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma (LA-NPC) remains undetermined. This study aimed to evaluate the benefits of IMRT...
4.
Liu G, Lv X, Wu Y, Mao M, Ye Y, Yu Y, et al.
Cancer Commun (Lond)
. 2018 May;
38(1):21.
PMID: 29764487
Background: Available data in the literature comparing different induction chemotherapy (IC) regimens on locoregionally advanced nasopharyngeal carcinoma (NPC) are scarce. The purpose of the present study was to evaluate the...
5.
Qiu W, Zhang H, Xia W, Ke L, Yang J, Yu Y, et al.
J Exp Clin Cancer Res
. 2018 Apr;
37(1):85.
PMID: 29665837
Background: Distant metastasis is the major cause of treatment failure in patients with nasopharyngeal carcinoma (NPC). Although several biomarkers correlate with metastasis and prognosis, the molecular mechanisms of NPC development...
6.
Qiu W, Ke L, Xia W, Yang J, Yu Y, Liang H, et al.
PLoS One
. 2017 Aug;
12(8):e0182963.
PMID: 28797119
Background: To evaluate the clinical characteristics, treatment-related toxicities and survival in patients with nasopharyngeal carcinoma (NPC) with or without oropharyngealcandidiasis (OPC) during radiotherapy. Methods: The current study was conducted with...
7.
Ke L, Xia W, Qiu W, Huang X, Yu Y, Liang H, et al.
Oral Oncol
. 2017 Jun;
70:7-13.
PMID: 28622892
Objectives: Nanoparticle albumin-bound paclitaxel (NAB-paclitaxel) was designed to avoid solvent-related toxicities, and improve anti-tumor efficacy via increasing paclitaxel's intratumoral concentration and its uptake by tumor cells. This trial aimed to...
8.
Xia W, Liang H, Lv X, Wang L, Qian C, Ye Y, et al.
Oral Oncol
. 2017 Mar;
67:167-174.
PMID: 28351572
Objective: To compare the effectiveness of concurrent cisplatin chemoradiotherapy plus cetuximab with that of concurrent chemoradiotherapy (CCRT) alone in locoregionally advanced nasopharyngeal carcinoma (LRANPC) patients. Materials And Methods: A total...
9.
Ke L, Xia W, Qiu W, Huang X, Yang J, Yu Y, et al.
BMC Cancer
. 2017 Feb;
17(1):134.
PMID: 28202000
Background: Due to improvements in imaging and radiological techniques as well as the use of chemotherapy, distant metastasis has become the predominant mode of treatment failure in patients with locally...
10.
Liang H, Xiang Y, Lv X, Xie C, Cao S, Wang L, et al.
Eur J Cancer
. 2017 Feb;
73:48-60.
PMID: 28161498
Background: Whether the waiting time for radical radiotherapy (WRT) detrimentally impacts nasopharyngeal carcinoma (NPC) prognosis is unclear. We estimated the influence of WRT on overall survival (OS) and disease-specific survival...